Cargando…

Evaluation of plasma levels of tissue factor and tissue factor pathway inhibitor in patients with psoriasis

INTRODUCTION: Psoriasis is a chronic, recurrent, inflammatory skin disorder with systemic involvement. It has recently been established that psoriasis is associated with an increased cardiovascular risk. Chronic skin-specific inflammation may promote atherosclerosis. Myocardial infarction or stroke...

Descripción completa

Detalles Bibliográficos
Autores principales:	Domagała, Anna, Wojtowicz-Prus, Elżbieta, Dubis, Joanna, Witkiewicz, Wojciech, Czarnecka, Anna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2019
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6791144/ https://www.ncbi.nlm.nih.gov/pubmed/31616219 http://dx.doi.org/10.5114/ada.2019.87447

Ejemplares similares

Importance of sonography of the skin and subcutaneous tissue in the early diagnosis of melanoma in-transit metastasis with the presentation of two cases
por: Czarnecka, Anna, et al.
Publicado: (2018)

The role of the tissue factor and its inhibitor in the development of subclinical atherosclerosis in people living with HIV
por: Barska, Katarzyna, et al.
Publicado: (2017)

Correlates of plasma and platelet tissue factor pathway inhibitor, factor V, and Protein S
por: Ellery, Paul E. R., et al.
Publicado: (2017)

Tissue Factor and Tissue Factor Pathway Inhibitor in Chronically Inflamed Gallbladder Mucosa
por: Liczko, Jacek, et al.
Publicado: (2014)

An Observational Study of 147 Psoriasis Patients: Overweightness and Obesity as a Significant Clinical Factors Correlated with Psoriasis
por: Czarnecka, Anna, et al.
Publicado: (2023)

The Levels of Tissue Factor Pathway Inhibitor in Sepsis Patients Receiving Prophylactic Enoxaparin
por: Al Otair, Hadil A., et al.
Publicado: (2016)

From Primary MSC Culture of Adipose Tissue to Immortalized Cell Line Producing Cytokines for Potential Use in Regenerative Medicine Therapy or Immunotherapy
por: Paprocka, Maria, et al.
Publicado: (2021)

Coagulation disorders and the role of tissue factor and tissue factor pathway inhibitor in critically ill patients
por: Frantzeskaki, F, et al.
Publicado: (2015)

Interleukin 6 and 8 Levels in Plasma and Fibroblast Cultures in Psoriasis
por: Zalewska, Anna, et al.
Publicado: (2006)

Low levels of tissue factor pathway inhibitor increase the risk of cerebral venous thrombosis
por: Javanmard, Shaghayegh Haghjooy, et al.
Publicado: (2015)

Antihistamines in the treatment of pruritus in psoriasis
por: Domagała, Anna, et al.
Publicado: (2017)

Associations of Genes for Killer Cell Immunoglobulin-like Receptors and Their Human Leukocyte Antigen-A/B/C Ligands with Abdominal Aortic Aneurysm
por: Dubis, Joanna, et al.
Publicado: (2021)

Homology modeling and structural validation of tissue factor pathway inhibitor
por: Agrawal, Piyush, et al.
Publicado: (2013)

Increased Thrombin-Activatable Fibrinolysis Inhibitor and Decreased Tissue Factor Pathway Inhibitor and Thrombomodulin Levels in Children with Hypothyroidism
por: Alioğlu, Bülent, et al.
Publicado: (2012)

Decreased brain-derived neurotrophic factor plasma levels in psoriasis patients
por: Brunoni, A.R., et al.
Publicado: (2015)

The Imbalance Between Metalloproteinases and Their Tissue Inhibitors Is Involved in the Pathogenesis of Dermatitis Herpetiformis
por: Zebrowska, Agnieszka, et al.
Publicado: (2005)

Expression of tissue factor and tissue factor pathway inhibitors during ovulation in rats: a relevance to the ovarian hyperstimulation syndrome
por: Jang, You Jee, et al.
Publicado: (2021)

Factors that Affect the Content of Cadmium, Nickel, Copper and Zinc in Tissues of the Knee Joint
por: Roczniak, Wojciech, et al.
Publicado: (2017)

Two New Cases of KIR3DP1, KIR2DL4-Negative Genotypes, One of which is also Lacking KIR3DL2
por: Niepiekło-Miniewska, Wanda, et al.
Publicado: (2014)

The genetic variation rs6903956 in the novel androgen-dependent tissue factor pathway inhibitor regulating protein (ADTRP) gene is not associated with levels of plasma coagulation factors in the Singaporean Chinese
por: Chang, Xuling, et al.
Publicado: (2017)

Coexpression of heparanase activity, cathepsin L, tissue factor, tissue factor pathway inhibitor, and MMP-9 in proliferative diabetic retinopathy
por: Abu El-Asrar, Ahmed M., et al.
Publicado: (2016)

A low balance between microparticles expressing tissue factor pathway inhibitor and tissue factor is associated with thrombosis in Behçet’s Syndrome
por: Khan, E., et al.
Publicado: (2016)

Progress in the Development of Anti-tissue Factor Pathway Inhibitors for Haemophilia Management
por: Mahlangu, Johnny N.
Publicado: (2021)

Regulation of coagulation by tissue factor pathway inhibitor: Implications for hemophilia therapy
por: Mast, Alan E., et al.
Publicado: (2022)

Tissue Factor Pathway Inhibitors as Potential Targets for Understanding the Pathophysiology of Preeclampsia
por: Kobayashi, Hiroshi, et al.
Publicado: (2023)

Connective Tissue Growth Factor Neutralization Aggravates the Psoriasis Skin Lesion: The Analysis of Psoriasis Model Mice and Patients
por: Hayakawa, Kunihiro, et al.
Publicado: (2018)

Expression of Matrix Metalloproteinases and Their Tissue Inhibitors in Peripheral Blood Leukocytes and Plasma of Children with Nonalcoholic Fatty Liver Disease
por: Trojanek, Joanna B., et al.
Publicado: (2020)

Psoriasis and Connective Tissue Diseases
por: Yamamoto, Toshiyuki
Publicado: (2020)

The Role of Epigenetic Factors in Psoriasis
por: Dopytalska, Klaudia, et al.
Publicado: (2021)

Simultaneous expression of tissue factor and tissue factor pathway inhibitor by human monocytes. A potential mechanism for localized control of blood coagulation
Publicado: (1994)

The possibilities and principles of methotrexate treatment of psoriasis – the updated knowledge
por: Czarnecka-Operacz, Magdalena, et al.
Publicado: (2014)

Factor V‐short and protein S as synergistic tissue factor pathway inhibitor (TFPIα) cofactors
por: Dahlbäck, Björn, et al.
Publicado: (2017)

Correlation of Endostatin and Tissue Inhibitor of Metalloproteinases 2 (TIMP2) Serum Levels With Cardiovascular Involvement in Systemic Sclerosis Patients
por: Dziankowska-Bartkowiak, Bożena, et al.
Publicado: (2005)

Tissue factor pathway inhibitor-2 induced hepatocellular carcinoma cell differentiation
por: Li, Ziwei, et al.
Publicado: (2017)

A shared tissue transcriptome signature and pathways in psoriasis and ulcerative colitis
por: Xi, Li, et al.
Publicado: (2022)

Toll-Like Receptor 9 Signaling Regulates Tissue Factor and Tissue Factor Pathway Inhibitor Expression in Human Endothelial Cells and Coagulation in Mice
por: El Kebir, Driss, et al.
Publicado: (2015)

Tissue Factor-Expressing Tumor Cells Can Bind to Immobilized Recombinant Tissue Factor Pathway Inhibitor under Static and Shear Conditions In Vitro
por: Che, Sara P. Y., et al.
Publicado: (2015)

Methaemalbumin: a diagnostic surrogate for methaemoglobinaemia and treatment with red cell exchange in a patient with thalassaemia
por: Prus-Czarnecka, Zofia, et al.
Publicado: (2023)

Evaluation of four commercial ELISAs to measure tissue factor in human plasma
por: Sachetto, Ana T.A., et al.
Publicado: (2023)

An Update on the Role of Adipose Tissues in Psoriasis
por: Wong, Yisheng, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_3n1htrb4u4j0faktrh4dr1vqib